Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: May 20, 2024
Abstract
Tumor
biomarkers,
the
substances
which
are
produced
by
tumors
or
body’s
responses
to
during
tumorigenesis
and
progression,
have
been
demonstrated
possess
critical
encouraging
value
in
screening
early
diagnosis,
prognosis
prediction,
recurrence
detection,
therapeutic
efficacy
monitoring
of
cancers.
Over
past
decades,
continuous
progress
has
made
exploring
discovering
novel,
sensitive,
specific,
accurate
tumor
significantly
promoted
personalized
medicine
improved
outcomes
cancer
patients,
especially
advances
molecular
biology
technologies
developed
for
detection
biomarkers.
Herein,
we
summarize
discovery
development
including
history
conventional
innovative
used
biomarker
classification
biomarkers
based
on
tissue
origins,
application
clinical
management.
In
particular,
highlight
recent
advancements
biomarker-based
anticancer-targeted
therapies
emerging
as
breakthroughs
promising
strategies.
We
also
discuss
limitations
challenges
that
need
be
addressed
provide
insights
perspectives
turn
into
opportunities
this
field.
Collectively,
multiple
emphasized
review
may
guidance
precision
medicine,
broaden
horizons
future
research
directions,
expedite
patients
according
their
rather
than
organs
origin.
Chemical Reviews,
Journal Year:
2022,
Volume and Issue:
122(6), P. 6850 - 6918
Published: March 2, 2022
Photoacoustic
(PA)
imaging
technology,
a
three-dimensional
hybrid
modality
that
integrates
the
advantage
of
optical
and
acoustic
imaging,
has
great
application
prospects
in
molecular
due
to
its
high
depth
resolution.
To
endow
PA
with
ability
for
real-time
visualization
precise
biomedical
diagnosis,
numerous
activatable
probes
which
can
specifically
alter
their
intensities
upon
reacting
targets
or
biological
events
interest
have
been
developed.
This
review
highlights
recent
developments
applications
including
detection
biotargets
events.
First,
generation
mechanism
signals
will
be
given,
followed
by
brief
introduction
contrast
agents
used
probe
design.
Then
we
particularly
summarize
general
design
principles
alteration
strategies
developing
probes.
Furthermore,
give
detailed
discussion
living
systems.
At
last,
current
challenges
outlooks
future
discussed.
We
hope
this
stimulate
new
ideas
explore
potentials
future.
Journal of the American Chemical Society,
Journal Year:
2019,
Volume and Issue:
141(34), P. 13572 - 13581
Published: Aug. 1, 2019
Cancer
treatments
are
confounded
by
severe
toxic
effects
toward
patients.
To
address
these
issues,
activatable
nanoprobes
have
been
designed
for
specific
imaging
and
destruction
of
cancer
cells
under
the
stimulation
cancer-associated
biomarkers.
Most
were
usually
activated
some
single-factor
stimulation,
but
this
restricts
therapeutic
specificity
between
diseased
normal
tissue;
therefore,
multifactor
activation
is
highly
desired.
end,
we
herein
develop
a
novel
dual-stimuli
responsive
theranostic
nanoprobe
simultaneously
photothermal
therapy
coactivation
"dual-key"
"nitric
oxide
(NO)/acidity",
so
as
to
further
improve
specificity.
Specifically,
integrated
weak
electron
acceptor
(benzo[c][1,2,5]thiadiazole-5,6-diamine)
into
donor−π-acceptor−π-donor
type
chromophore.
When
was
oxidized
NO
in
acidic
conditions
form
stronger
(5H-[1,2,3]triazolo[4,5-f]-2,1,3-benzothiadiazole),
molecule
absorption
significantly
increased
near-infrared
region,
based
on
intramolecular
charge
transfer
(ICT)
mechanism.
Under
dual-key
NO/acidity
within
tumor
associated
with
inflammation,
can
correspondingly
output
dual
signals
ratiometric
photoacoustic
vivo
do
enhanced
accuracy
Our
exhibited
higher
signal
enhancement
dual-factor
at
9.8
times
that
132
acidity
alone,
respectively.
Moreover,
through
such
NO/acidity,
produces
more
differentiation
hyperthermia
tissues,
afford
satisfactory
minimal
side
effects.
Thus,
our
work
presents
promising
strategy
improving
precision
therapy.
Angewandte Chemie International Edition,
Journal Year:
2019,
Volume and Issue:
58(38), P. 13208 - 13219
Published: April 17, 2019
Conventional
analytical
methods
based
on
the
detection
of
a
single
disease
marker
may
not
be
sufficiently
accurate
because
progression
generally
involves
multiple
chemicals
and
biomolecules.
The
drive
for
simultaneous
analysis
targets,
which
plays
key
role
in
both
basic
biomedical
research
clinical
applications,
demands
development
multiplexed
bioassays
with
high-throughput.
In
this
minireview,
we
summarize
recent
progress
optical
techniques
improving
diagnostics,
fluorescence
surface
enhanced
Raman
scattering
(SERS)
distinctive
features
are
chosen
as
main
readout
signals.
Focusing
strategies
field,
selection
contributions
from
biosensing
analytes
multicolor
cellular
tracking
to
vivo
bioimaging
highlighted.
Finally,
frame
future
challenges
opportunities
bioanalysis.
Chemical Science,
Journal Year:
2019,
Volume and Issue:
10(36), P. 8348 - 8353
Published: Jan. 1, 2019
Theranostic
nanoprobes
(SYL
NPs)
prepared
from
a
newly
designed
NIR-II
fluorophore
and
FDA
approved
DSPE-mPEG5000
were
well
tolerated
exhibited
multifunctional
potential
in
diagnosis
(photoacoustic
&
fluorescence
imaging)
phototherapy
animal
models.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: May 20, 2024
Abstract
Tumor
biomarkers,
the
substances
which
are
produced
by
tumors
or
body’s
responses
to
during
tumorigenesis
and
progression,
have
been
demonstrated
possess
critical
encouraging
value
in
screening
early
diagnosis,
prognosis
prediction,
recurrence
detection,
therapeutic
efficacy
monitoring
of
cancers.
Over
past
decades,
continuous
progress
has
made
exploring
discovering
novel,
sensitive,
specific,
accurate
tumor
significantly
promoted
personalized
medicine
improved
outcomes
cancer
patients,
especially
advances
molecular
biology
technologies
developed
for
detection
biomarkers.
Herein,
we
summarize
discovery
development
including
history
conventional
innovative
used
biomarker
classification
biomarkers
based
on
tissue
origins,
application
clinical
management.
In
particular,
highlight
recent
advancements
biomarker-based
anticancer-targeted
therapies
emerging
as
breakthroughs
promising
strategies.
We
also
discuss
limitations
challenges
that
need
be
addressed
provide
insights
perspectives
turn
into
opportunities
this
field.
Collectively,
multiple
emphasized
review
may
guidance
precision
medicine,
broaden
horizons
future
research
directions,
expedite
patients
according
their
rather
than
organs
origin.